Company Directory > MedTech > Instituto Dante Pazzanese de Cardiologia (IDPC)
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Instituto Dante Pazzanese de Cardiologia (IDPC) and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
The Instituto Dante Pazzanese de Cardiologia (IDPC) is a premier public cardiovascular hospital and research center based in São Paulo, Brazil. It operates under the State Secretariat of Health and is associated with the University of São Paulo (USP) for teaching and research purposes. The institute is a pioneer in cardiovascular medicine, known for its contributions to surgical techniques, stent development, and personalized medicine. It serves as a major hub for clinical trials, biobanking, and the development of medical devices through its specialized bioengineering division.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:-
Industry:Medical Devices
Sub-Industry:Cardiovascular Research and Clinical Care
SIZE & FINANCIALS
Employees:1001-5000
Founded:1954
Ownership:government
Status:operating
PIPELINE
Stage:Clinical
Lead Drug Stage:N/A
Modalities:Medical Devices, Surgical Procedures
Active Trials:1
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Fundação Adib Jatene (Support Foundation), University of São Paulo (Academic Partner), Meril Life Sciences (Device Partner), Edwards Lifesciences (Device Partner)
COMPETITION
Position:Leader
LEADERSHIP
Key Executives:
Fausto Feres - Director
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Instituto Dante Pazzanese de Cardiologia (IDPC). The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.